BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33172389)

  • 1. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
    Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
    BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM
    Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database.
    Chen C; Wu Z; Wu Z; Wu C; Wang Q; Zhan T; Dong L; Fang S; Wu M
    BMC Cancer; 2021 Jun; 21(1):666. PubMed ID: 34088283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
    Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
    J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of lung cancer after a previous malignancy.
    Reinmuth N; Stumpf P; Stumpf A; Muley T; Kobinger S; Hoffmann H; Herth FJ; Schnabel PA; Bischoff H; Thomas M
    Respir Med; 2014 Jun; 108(6):910-7. PubMed ID: 24650574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study.
    Wu LL; Li CW; Lin WK; Qiu LH; Xie D
    BMC Cancer; 2021 Sep; 21(1):1009. PubMed ID: 34496775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
    Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
    Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
    Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database.
    Li Y; Hu S; Xie J; Zhang X; Zong Y; Xu B; Li C
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2397-2404. PubMed ID: 31302755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favourable prognostic factors in therapy related acute myeloid leukaemia.
    Antonijević N; Suvajdziĉ N; Terzić T; Jakovljević B; Janković G; Elezović I; Milosević R; Colović M
    Srp Arh Celok Lek; 2011; 139(5-6):347-52. PubMed ID: 21858974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
    Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
    BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
    Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
    Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
    Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
    BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.
    Brown CA; Youlden DR; Aitken JF; Moore AS
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27410. PubMed ID: 30183136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis.
    Zhong J; Zheng Q; An T; Zhao J; Wu M; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    Thorac Cancer; 2019 Sep; 10(9):1788-1797. PubMed ID: 31318178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.